ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY

Rosen Law Firm is soliciting investors for multiple securities class action lawsuits. The primary case involves Unicycive Therapeutics, which allegedly made false statements about its manufacturing vendor's FDA compliance and the regulatory approval timeline for its drug oxylanthanum carbonate. The firm is also handling class actions for FuelCell Energy and GoDaddy, with lead plaintiff deadlines approaching in November 2026.